Related Experiment Video
Updated: Jun 10, 2026

06:53
A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Follow-up Study after Intracranial Percutaneous Transluminal Cerebral Balloon Angioplasty
1Department of Stroke Treatment, Shonan Kamakura General Hospital; Kanagawa, Japan - morit-koc@umin.ac.jp.
Summary
Intracranial percutaneous transluminal cerebral angioplasty (PTCBA) is most effective for simple (Type A) lesions, showing a 92% success rate. Complex lesions (Types B and C) had significantly lower success rates and higher risks of stroke or bypass surgery.
Area of Science:
- Neurology
- Interventional Neuroradiology
- Vascular Surgery
Background:
- Intracranial atherosclerotic stenosis poses a significant risk of stroke.
- Percutaneous transluminal cerebral angioplasty (PTCBA) is a treatment option for these lesions.
- Predicting PTCBA outcomes based on lesion characteristics is crucial for patient selection.
Purpose of the Study:
- To identify specific angiographic characteristics of intracranial lesions that predict successful PTCBA outcomes.
- To evaluate the efficacy and safety of PTCBA in relation to lesion morphology.
Main Methods:
- A retrospective analysis of 42 patients with symptomatic intracranial lesions treated with PTCBA between 1992 and 1996.
- Classification of lesions into three types based on angiographic features: Type A (simple, concentric), Type B (tubular/eccentric), and Type C (diffuse).
- Comparison of clinical success rates and cumulative risks of adverse events (death, stroke, bypass surgery) across the three lesion types.
Main Results:
- Clinical success rates varied significantly by lesion type: 92% for Type A, 86% for Type B, and 33% for Type C (p=0.0032).
- Cumulative risks of stroke or bypass surgery were lowest in Type A (8%), intermediate in Type B (26%), and highest in Type C (87%) (p < 0.0001).
- Type A lesions demonstrated a favorable outcome with a low cumulative risk of 8%.
Conclusions:
- PTCBA for simple (Type A) intracranial lesions yields favorable clinical outcomes in symptomatic patients.
- Complex lesion morphologies (Type B and C) are associated with significantly lower success rates and higher risks of adverse cerebrovascular events.
- Angiographic lesion characteristics are critical determinants of PTCBA efficacy and safety.
